BL-001
phase 1drug program · high · Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Oral once-daily live biotherapeutic intended to reverse-engineer ketogenic biology into a scalable medicine for metabolic and neurological disorders, including obesity and Developmental & Epileptic Encephalopathies such as Dravet syndrome.
Live biotherapeutic medicine targeting the gut-brain axis; evaluated in a Phase Ia safety and tolerability study in healthy volunteers for 28 consecutive days.
Phase Ia safety and tolerability study of BL-001 in healthy volunteers.
Alzheimer's Program
undiscloseddrug program · medium
Develop live biotherapeutic medicines for Alzheimer's disease.
Pipeline program within Bloom Science's live biotherapeutic gut-brain-axis approach.
Listed in Bloom Science pipeline.
Amyotrophic Lateral Sclerosis Program
undiscloseddrug program · medium
Develop live biotherapeutic medicines for amyotrophic lateral sclerosis.
Pipeline program within Bloom Science's live biotherapeutic gut-brain-axis approach.
Listed in Bloom Science pipeline.
Dravet Syndrome and Developmental & Epileptic Encephalopathies Program
undiscloseddrug program · medium
Develop live biotherapeutic medicines for Dravet syndrome and Developmental & Epileptic Encephalopathies.
Gut-brain-axis live biotherapeutic approach based on ketogenic biology; BL-001 is described as being advanced in Developmental & Epileptic Encephalopathies including Dravet syndrome.
Listed in Bloom Science pipeline as an active focus area.
Gut-Brain Axis Live Biotherapeutics Platform
exploratoryplatform · high
Create next-generation live biotherapeutic medicines targeting the gut-brain axis for metabolic and neurological disorders.
Live biotherapeutics platform using ketogenic biology as a basis for scalable therapeutic programs.
Platform described as supporting Bloom Science's pipeline, including BL-001.
Neuropsychiatric Conditions Program
undiscloseddrug program · medium
Develop live biotherapeutic medicines for neuropsychiatric conditions.
Pipeline program within Bloom Science's live biotherapeutic gut-brain-axis approach.
Listed in Bloom Science pipeline.
Obesity and Metabolic Syndromes Program
undiscloseddrug program · medium
Develop live biotherapeutic medicines for obesity and metabolic syndromes.
Gut-brain-axis live biotherapeutic approach based on ketogenic biology; BL-001 is described as being advanced in obesity.
Listed in Bloom Science pipeline as an active focus area.
